Pharmabit: Accelerating the Vaccine Discovery Process

Here I am, writing an article during my quarantine. Our lives have been changed drastically with many families facing the horrors of the virus first hand.

The crazy part is, this isn’t rare. Over the past decades and centuries, many human populations have been wiped out by plagues, pandemics, and infectious diseases. Events like the Spanish Influenza, H1N1 Swine Flu Pandemic, Polio, Ebola.

The list goes on.

The diseases that we were once scared of are now gone. But here’s the reality: these infectious diseases will only get stronger.

It’s science, it’s nature, and you can thank Darwin. The idea of Natural Selection- where the most reproductively successful will survive and produce the next generation of organisms- has been a great advantage for us as humans, but also could lead to the brink of our extinction.

Natural selection in action

So far, we’ve been able to advance our technology by quite a bit, but it hasn’t been enough. The only way we can outsmart these infectious diseases is simply, by building immunity! However, the solution right now is the problem.

Breaking Down Why a Virus is the Biggest Threat to Us

The main difference between a drug and a vaccine is that a vaccine helps the body to build immunity and kill off a virus, whereas a drug actually does the dirty work. With vaccines, it can help prevent the infection of the virus and an overload of patients since they are immune to the virus.

But discovery a drug isn’t that easy. The image above is the usual R&D process and it’s a long time for a fully approved drug to roll out on the markets. On top of this, most drugs end up failing in human trials because they end up being safe and ineffective. The reason being- what works in a lab may not work in the body. Especially with vaccines.

Our bodies are so complex and there are so many components that work together; simply testing cells and vaccine candidates in-vitro won’t produce the same results as a test in the body. To get the most effective and safe drug for humans, the R&D process should maintain randomized trials so that the data is minimally biased.

A lot goes into make the optimal drug

Okay, so the drug discovery process is safe, but it’s still long. With Pharmabit, our goal is to accelerate this process by stimulating the body and drugs so we can find the most efficient and safe vaccine to stop deadly pandemics once and for all.

That’s where we come in 😝

Step 1: Identifying the Virus and it’s DNA Structure

To identify if the virus is infectious, scientists use Koch’s postulates. These are 4 basic rules that enable us to recognize if the virus is infectious or not. The 4 rules are:

  1. The organism must be found in people with the disease and be absent in people without the disease.
  2. The organism must be able to be grown from tissues or other specimens from the affected individual in the laboratory.
  3. The organism must cause the disease when given to an unaffected healthy person.
  4. The organism must again be grown from this second individual.

After identifying We have many techniques for different organisms with an accurate one being the Polymerase Chain Reaction (PCR). In this test, we can amplify and anneal certain segments of viral DNA/RNA and find the sequence of the virus. Based on previous outbreaks and pandemics, our system will be able to trace back similar DNA/RNA sequences, how similar they are, and potential vaccine candidates.

Taking advantage of Immunological Memory

Essentially, here we see that our bodies first recognize an antigen, build antibodies ad bind to the cell with the surface antigen. From there on, T-Cells kill all the cells with the certain antigen exposed.

Vaccines usually aim to build that immunity by exposing our bodies to these antigens. At Pharmabit, our goal is to utilize the DNA/RNA sequence to trace back similarities between other past viruses, their vaccine candidates and hypothesize the repurposing of them.

Moreover, since antigens are proteins built by the viral nucleotide sequence, our goal is to predict the antigenic cartography of the strain. By analyzing the sequence at which the virus produces the specific antigen, we would be able to accelerate the process of the production of DNA vaccines.

Simulating the Effect on the Human Body

We would work to recognize different epigenetic and genetic biomarkers on B-Cells which help build the body antibodies and use the sequence to build protein-profiles.

By building these protein profiles, we would be able to predict the motion and probabilities of the immune response on these populations. We would use parallel computational powers and Quantum Annealing to find the optimal DNA vaccine and advance the testing process.

A Quick Intro into Quantum Annealing and How it Works

At Pharmabit, we are looking to optimize to find the most effective dosage to build a sufficient amount of antibodies.

In order for this to work, we would be solving an energy optimization problem. Most things aim to find its lowest energy state; when you heat something up, you’re essentially increasing the kinetic energy, and by cooling it down, it’s finding the lowest energy state. In our case, we wouldn’t be actually solving for the bottom line lowest, but other candidate options that could maximize our results.

Quantum Computing is really weird, but it’s so fascinating. In order to accomplish our goal, qubits, which have the special power to be in a superposition (in between 0 and 1 rather than 0 or 1) will be forced using biases to be pushed into the state of 0 or 1. These biases can influence whether it becomes a 0 or 1.

We will also use couplers to entangle qubits, which would be favored to either be opposite or the same as each other. For example, if one qubit is 0, we could favour it to be a 1 which lowers the lowest energy state. With a complex series of couplers and biases, the quantum computer will be programmed and will find the minimum energy level- in our case, the best vaccine candidate.

Where are we Now?

At the moment, IBM has their cloud quantum computing options opened with over 150 billion programs run on it; for COVID-19, using existing data, they have been able to identify 77 potential drug candidates.

IBM’s Quantum Computer

The problem right now is how we haven’t quite been able to map out the immune response of B-Cells using the nucleotide sequential data from the pathogen. At Pharmabit, our goal is to accelerate the process, by working with leading quantum experts so we could reach our vision.

Our main goal at the moment is to ensure that we first accelerate the technology before anything else. For the next 5 years, we hope to develop and continuously test our quantum annealing technologies. We will have a main focus on gaining more data on the microscopic level prior to simulating it. In 2026, we hope that researchers are testing our technology so we can help put these pandemics to an end.

Key Takeaways

2. Using our Quantum computing program, we identify potential vaccines from previous pandemic/viral outbreaks

3. Predict the antigenic cartography and build a vaccine

4. Simulate that on the human body and accelerate the long discovery process

And that’s how we plan to save the world.

Thanks for reading this article! If you also want to help us save the world, you can:

  • Visit our website to learn more
  • Shoot us an email at info@pharmabit.ca
  • Connect with me on Linkedin and chat
  • Shoot me an email at ahashganeshamoorthy@gmail.com to chat

Hey there! I am a young innovator based in The Knowledge Society working on utilizing CRISPR technology to cure disease!

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store